01 Jamieson cytomegalovirus 508
Document text
ACIP Cytomegalovirus (CMV) Vaccines Workgroup Introduction Denise Jamieson, MD Chair, CMV Vaccines Workgroup April 15th, 2025National Center for Immunization & Respiratory Diseases ACIP Members •Denise Jamieson (WG chair) •Bonnie Maldonado Liaisons •David Kimberlin (AAP) •Liat Greenwood Chernoff (ACNM) •Naima Joseph (ACOG) •Tabitha Hanson (AIM) •Leisha Nolen (CSTE) •Ajit Limaye (IDSA) •Caleb Lyu (NACCHO) •Maria Carrillo -Marquez (PIDS)ACIP CMV WG Members Ex Officio Members •Douglas Pratt (FDA) •Britt Rizek (HRSA) •Matthew Clark (IHS) Consultants •Andrea Ciaranello (Harvard Medical School) •Rana Chakraborty (University of Miami) •Sonja Rasmussen (Johns Hopkins University) •Martina Badell (SMFM) CDC Staff - DVD •Tatiana Lanzieri (WG co -lead) •David Sugerman (WG co -lead) CDC Staff - DVD •Tom Clark (ACIP advisor) •Sara Oliver (ACIP advisor) •Dan Filardo •Jessica Leung •Chelsea Lutz •Lois Park •Kelley Raines •Ashrita Rau •Brian WakemanACIP CMV WG CDC Participants CDC Staff - non-DVD •Amimah Asif (ISD) •Karen Pazol (ISD) •Christine Olson (ISO) •Elizabeth Quincer (ISO) •Kate Woodworth (DBDID) •Alison Fountain (DBDID) •Naomi Tepper (DRH) ACIP Staff •Melinda Wharton •Jessica MacNeil •Leslie Lee •Stephanie Thomas a.CMV and congenital CMV (cCMV) epidemiology and disease burden Dr. Tatiana Lanzieri (WG co -lead) b.CMV vaccine safety and immunogenicity data Dr. Robert Paris (Moderna) c.Initial work group considerations for CMV vaccine policy Dr. Tatiana Lanzieri d.DiscussionACIP CMV Vaccines Workgroup